Today: 9 April 2026
Boeing stock price dips despite Ethiopian Dreamliner order as BA heads into earnings spotlight
20 January 2026
1 min read

Boeing stock price dips despite Ethiopian Dreamliner order as BA heads into earnings spotlight

New York, January 20, 2026, 14:48 EST — Regular session

Boeing shares slipped slightly Tuesday after Ethiopian Airlines placed an order for nine 787-9 Dreamliners and finalized the purchase of 11 737 MAX jets, the companies confirmed. The stock traded around $247.13 in the afternoon, down about 0.2%, after fluctuating between $240.08 and $248.43. Ethiopian Airlines Group CEO Mesfin Tasew said, “We will continue to acquire more aircraft and adopt the latest technologies as part of our strategic vision to advance sustainable aviation.” Reuters

The order itself is modest, arriving as investors sift through the gap between demand headlines and actual deliveries. For Boeing, the key question remains whether it can turn its full order book into delivered planes—and cash in hand.

The 787 Dreamliner is a widebody, twin-aisle jet designed for long-haul flights. The 737 MAX, by contrast, is a narrowbody, single-aisle aircraft that dominates short-haul routes and drives a large chunk of the sector’s volume.

Boeing confirmed that two orders finalized in December 2025 bring Ethiopian Airlines’ Boeing backlog to 20 planes, supporting the carrier’s growing network of 145 international destinations. “We are pleased to confirm the order for nine Boeing 787 Dreamliner aircraft to further expand our existing fleet,” Tasew said in a statement. Boeing’s vice president for Commercial Sales and Marketing in Africa, Anbessie Yitbarek, described the 787 family as “a game-changer.” Boeing added that the 787 cuts fuel consumption and emissions by 25% compared to the aircraft it replaces. Boeing Investors

Financial terms weren’t disclosed. That’s significant since jetmakers usually receive most of a plane’s payment only upon delivery, not when the order is first announced.

With international travel demand firming and operating costs climbing, airlines are eager to secure more fuel-efficient planes. Delivery slots remain scarce, prompting carriers to commit to capacity years in advance.

Widebody orders help Boeing keep suppliers and customers in sync, but they don’t promise immediate results. The real bottleneck lies in production speed, where any hiccup quickly impacts shipment schedules and working capital.

The downside risks remain. Parts shortages, quality issues, or stricter regulatory scrutiny could disrupt production. Airlines might also push back deliveries if traffic dips or financing costs rise.

Traders are now focused on upcoming data and any shifts in production tone, beyond just new orders. With Airbus standing as the sole major competitor in the long-haul segment, changes in airline buying patterns continue to sway market sentiment.

Boeing’s upcoming milestone is its fourth-quarter 2025 earnings call, set for Jan. 27 at 10:30 a.m. EST. Investors will be watching closely for the 2026 delivery and cash flow outlook, which could shape BA’s trajectory into next week. Boeing Investors

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Amphenol (APH) stock slides on tariff jitters as investors eye Jan. 28 earnings
Previous Story

Amphenol (APH) stock slides on tariff jitters as investors eye Jan. 28 earnings

Roblox stock dives as tariff jitters hit risk names; age-check rollout back in focus
Next Story

Roblox stock dives as tariff jitters hit risk names; age-check rollout back in focus

Go toTop